Archer Aviation Is Well Below Its Production Targets. Here Are 3 Headwinds Facing the eVTOL Leader.

Archer targeted producing "up to 10" Midnight aircraft in 2025 but stopped reporting progress and appears to have fallen short, having worked on six concurrently mid-2025 and delivered at least one unit to Abu Dhabi. The company reported $2.0B in liquidity at end-2025 but is raising cash by selling shares, diluting existing shareholders. Regulatory uncertainty, technical complexity, and the need for final aircraft design approval remain key execution risks that constrain near-term production and commercialization.

Analysis

Archer’s communication silence on an earlier production objective is the symptom; the disease is a compound execution problem that spans certification, repeatable manufacturing and battery/thermal supply-chain readiness. Regulators create a moving target that converts what looks like a manufacturing ramp into a multi-year, milestone-driven program where the dominant value is de-risking certification, not chassis output—companies that demonstrate stable design freeze and predictable test outcomes will re-rate faster than those that merely promise volume.

Second-order winners are specialist suppliers and integrators who lock in long lead items (high-energy-density cells, high-torque electric motors, redundant flight controls) and can offer hardware that shortens certification cycles; losers are OEMs that rely on bespoke in-house supply stacks or vague supplier agreements. Infrastructure (vertiports, local airspace rules) will amplify winners: operators who secure municipal access and charging agreements will convert limited aircraft availability into outsized commercial revenue per unit.

Key tail risks are concentrated: a single public test failure or a protracted type-cert timeline can wipe out current equity valuations within weeks; conversely, an accelerated FAA/CAA acceptance of a common safety baseline would compress uncertainty and trigger a multi-quarter rerating. Expect catalyst cadence measured in quarters to years (regulatory filings, type-certificate milestones, formal supplier qualification rounds) rather than days, so position sizing and option tenors must reflect that horizon.

Key Decisions for Investors

• Short ACHR equity (size 1-3% portfolio) with a 6-12 month horizon: target 30-50% downside if execution/certification updates remain opaque; hedge tail-risk with a small long position in JOBY (see below) to limit black-swan counter-moves.
• Pairs trade — short ACHR / long JOBY 12-18 month calls (JOBY LEAPs): size pair 1-2% net exposure. Rationale: capture relative execution gap; if JOBY posts steady milestone wins, expect 30-60% upside on calls vs 30-50% downside on ACHR equity. Close or rebalance on first clear regulatory milestone from either firm.
• Buy 9–15 month ACHR puts (defined-risk) to express a time-limited negative view while limiting capital at risk; sell shorter-dated calls against the puts if volatility spikes to finance part of the premium — ideal if near-term liquidity events or raises are likely.
• Rotate a small allocation (0.5-1%) into NVDA (options or equity) as a macro risk-on hedge: NVDA tends to outperform in liquidity-driven rallies that lift loss-making growth cyclicals; use 6-12 month calls to capture asymmetric upside if risk appetite returns and speculative tech rallies lift small-cap aerospace sentiment.